Immler M, Wolfram M, Oevermann A, Walter I, Wolfesberger B, Tichy A
Vet Med Sci. 2024; 10(4):e1537.
PMID: 39011594
PMC: 11250153.
DOI: 10.1002/vms3.1537.
Grasberger H, Dumitrescu A, Liao X, Swanson E, Weiss R, Srichomkwun P
Nat Genet. 2024; 56(5):877-888.
PMID: 38714869
PMC: 11472772.
DOI: 10.1038/s41588-024-01717-7.
Goncalves-Reis M, Proenca D, Frazao L, Neto J, Silva S, Pinto-Marques H
Pract Lab Med. 2024; 39:e00365.
PMID: 38371895
PMC: 10869278.
DOI: 10.1016/j.plabm.2024.e00365.
Unkovic A, Bostjancic E, Belic A, Perse M
Biology (Basel). 2023; 12(2).
PMID: 36829468
PMC: 9952917.
DOI: 10.3390/biology12020190.
Barroux M, Horstmann J, Fricke L, Schomig L, Werner M, Kraynova E
Virchows Arch. 2022; 482(5):887-898.
PMID: 36527466
PMC: 10156762.
DOI: 10.1007/s00428-022-03471-9.
In-Depth Mass Spectrometry-Based Proteomics of Formalin-Fixed, Paraffin-Embedded Tissues with a Spatial Resolution of 50-200 μm.
Nwosu A, Misal S, Truong T, Carson R, Webber K, Axtell N
J Proteome Res. 2022; 21(9):2237-2245.
PMID: 35916235
PMC: 9767749.
DOI: 10.1021/acs.jproteome.2c00409.
Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole.
Griffin C, Paul C, Alexander K, Walker M, Hondermarck H, Lynam J
Neurooncol Adv. 2022; 4(1):vdab168.
PMID: 35047819
PMC: 8760897.
DOI: 10.1093/noajnl/vdab168.
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
Koutras A, Lazaridis G, Koliou G, Kouvatseas G, Christodoulou C, Pectasides D
PLoS One. 2018; 13(12):e0207707.
PMID: 30521571
PMC: 6283464.
DOI: 10.1371/journal.pone.0207707.
Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.
Christodoulou C, Oikonomopoulos G, Koliou G, Kostopoulos I, Kotoula V, Bobos M
Cancer Genomics Proteomics. 2018; 15(6):461-471.
PMID: 30343280
PMC: 6299784.
DOI: 10.21873/cgp.20105.
Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples.
Wimmer I, Troscher A, Brunner F, Rubino S, Bien C, Weiner H
Sci Rep. 2018; 8(1):6351.
PMID: 29679021
PMC: 5910432.
DOI: 10.1038/s41598-018-24781-6.
MGMT promoter methylation in Peruvian patients with glioblastoma.
Belmar-Lopez C, Castaneda C, Castillo M, Garcia-Corrochano P, Melendez B, Casavilca S
Ecancermedicalscience. 2018; 12:812.
PMID: 29515653
PMC: 5834313.
DOI: 10.3332/ecancer.2018.812.
Functional proteomics outlines the complexity of breast cancer molecular subtypes.
Gamez-Pozo A, Trilla-Fuertes L, Berges-Soria J, Selevsek N, Lopez-Vacas R, Diaz-Almiron M
Sci Rep. 2017; 7(1):10100.
PMID: 28855612
PMC: 5577137.
DOI: 10.1038/s41598-017-10493-w.
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.
Levva S, Kotoula V, Kostopoulos I, Manousou K, Papadimitriou C, Papadopoulou K
Cancer Genomics Proteomics. 2017; 14(3):181-195.
PMID: 28446533
PMC: 5420819.
DOI: 10.21873/cgp.20030.
Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy.
Kobayashi R, Miyagawa R, Yamashita H, Morikawa T, Okuma K, Fukayama M
Oncol Lett. 2016; 12(5):3066-3074.
PMID: 27899965
PMC: 5103900.
DOI: 10.3892/ol.2016.5054.
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer.
Omolo B, Yang M, Lo F, Schell M, Austin S, Howard K
BMC Med Genomics. 2016; 9(1):65.
PMID: 27756306
PMC: 5069826.
DOI: 10.1186/s12920-016-0225-2.
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
Gogas H, Kotoula V, Alexopoulou Z, Christodoulou C, Kostopoulos I, Bobos M
J Transl Med. 2016; 14(1):136.
PMID: 27184134
PMC: 4869295.
DOI: 10.1186/s12967-016-0883-z.
Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.
Laimito K, Gamez-Pozo A, Sepulveda J, Manso L, Lopez-Vacas R, Pascual T
Ecancermedicalscience. 2016; 10:632.
PMID: 27170832
PMC: 4854224.
DOI: 10.3332/ecancer.2016.632.
Straightforward and sensitive RT-qPCR based gene expression analysis of FFPE samples.
Zeka F, Vanderheyden K, Smet E, Cuvelier C, Mestdagh P, Vandesompele J
Sci Rep. 2016; 6:21418.
PMID: 26898768
PMC: 4761903.
DOI: 10.1038/srep21418.
Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
Lerut E, van Poppel H, Joniau S, Gruselle O, Coche T, Therasse P
Int J Clin Exp Pathol. 2015; 8(8):9522-32.
PMID: 26464715
PMC: 4583947.
Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.
Christophi G, Caza T, Curtiss C, Gumber D, Massa P, Landas S
Exp Mol Pathol. 2014; 96(3):393-9.
PMID: 24768588
PMC: 4048782.
DOI: 10.1016/j.yexmp.2014.04.006.